The AHR agonist VAF347 also increased receptor levels in RA-treated HL-60 cells concomitantly with their differentiation to a granulocytic lineage; further supporting that AHR upregulation in leukemia cells favors a differentiated phenotype (Ibabao et al., 2015). This evidence concerns the gene AHR and leukemia.